BioNote, Inc. (KRX:377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,570.00
+70.00 (1.27%)
At close: Nov 26, 2025

BioNote Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Operating Revenue
115,095102,78090,081479,657622,355631,505
Upgrade
Other Revenue
--0-0-0-
Upgrade
115,095102,78090,081479,657622,355631,505
Upgrade
Revenue Growth (YoY)
15.32%14.10%-81.22%-22.93%-1.45%1476.89%
Upgrade
Cost of Revenue
51,11251,807101,739139,186110,35251,950
Upgrade
Gross Profit
63,98350,973-11,659340,471512,003579,554
Upgrade
Selling, General & Admin
26,25422,86822,78731,51924,34013,102
Upgrade
Research & Development
15,69313,57713,40516,13811,3007,612
Upgrade
Amortization of Goodwill & Intangibles
1,0091,005858.1174.5144.1578.39
Upgrade
Other Operating Expenses
203.58265.78168.12176.92345.2945.46
Upgrade
Operating Expenses
45,58938,75635,51045,06243,25521,523
Upgrade
Operating Income
18,39412,218-47,168295,410468,748558,031
Upgrade
Interest Expense
-300.03-233.55-602.82-84.44-44.25-172.63
Upgrade
Interest & Investment Income
15,61020,05924,6309,715873.6337.56
Upgrade
Earnings From Equity Investments
107,07218,910--147,264--
Upgrade
Currency Exchange Gain (Loss)
17,58240,60310,16424,51224,159-5,726
Upgrade
Other Non Operating Income (Expenses)
-1.511,096420.84-296.63-123.11-75.83
Upgrade
EBT Excluding Unusual Items
158,35792,653-12,556181,992493,612552,094
Upgrade
Gain (Loss) on Sale of Investments
-18,676-14,511-88,791219,374376,239143,115
Upgrade
Gain (Loss) on Sale of Assets
-1,44820.25265.213,41233.39-11.45
Upgrade
Asset Writedown
-4,835-4,835-8,409---
Upgrade
Pretax Income
133,39873,327-109,491414,778869,885695,198
Upgrade
Income Tax Expense
15,74918,065-88,994106,980193,284166,969
Upgrade
Net Income
117,64955,261-20,497307,798676,601528,229
Upgrade
Net Income to Common
117,64955,261-20,497307,798676,601528,229
Upgrade
Net Income Growth
191.54%---54.51%28.09%2462.62%
Upgrade
Shares Outstanding (Basic)
101102102949494
Upgrade
Shares Outstanding (Diluted)
101102102949494
Upgrade
Shares Change (YoY)
-0.78%-0.08%8.16%0.64%0.14%11.08%
Upgrade
EPS (Basic)
1162.15542.36-200.993277.217232.045646.12
Upgrade
EPS (Diluted)
1160.96542.00-201.003264.007222.005646.00
Upgrade
EPS Growth
193.87%---54.81%27.91%2206.94%
Upgrade
Free Cash Flow
20,66147,454-8,156206,834485,966213,228
Upgrade
Free Cash Flow Per Share
203.95465.74-79.982193.655186.942279.15
Upgrade
Dividend Per Share
200.000200.000----
Upgrade
Gross Margin
55.59%49.59%-12.94%70.98%82.27%91.77%
Upgrade
Operating Margin
15.98%11.89%-52.36%61.59%75.32%88.37%
Upgrade
Profit Margin
102.22%53.77%-22.75%64.17%108.72%83.65%
Upgrade
Free Cash Flow Margin
17.95%46.17%-9.05%43.12%78.09%33.77%
Upgrade
EBITDA
27,23820,404-38,962301,861472,854559,918
Upgrade
EBITDA Margin
23.67%19.85%-43.25%62.93%75.98%88.66%
Upgrade
D&A For EBITDA
8,8458,1868,2066,4514,1061,887
Upgrade
EBIT
18,39412,218-47,168295,410468,748558,031
Upgrade
EBIT Margin
15.98%11.89%-52.36%61.59%75.32%88.37%
Upgrade
Effective Tax Rate
11.81%24.64%-25.79%22.22%24.02%
Upgrade
Advertising Expenses
-2,4222,4142,3321,063540.13
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.